A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia

Status:
Terminated

Trial end date:
2017-08-07

Target enrollment:

Participant gender:

A Single-Dose Study to Evaluate the Effects of ABX-1431 on Gastric Accommodation and Nutrient Volume Tolerance in Patients with Functional Dyspepsia.

Phase 1

Abide Therapeutics